Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience.

CONCLUSIONS: HCQ effectively and safely reduces proteinuria in IgAN patients with different levels of eGFR, supporting the maintenance of stable kidney function in the long term.
PMID: 33591553 [PubMed - as supplied by publisher]

Source: Journal of Nephrology - February 16, 2021 Category: Urology & Nephrology Authors: Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H Tags: J Nephrol Source Type: research